Neoadjuvant Endocrinotherapy of Breast Cancer (Mamma Carcinoma) With Exemestane
Clinical trial NCT00291798 · COMPLETED
Trial details
- NCT number
- NCT00291798
- Sponsor
- Austrian Breast & Colorectal Cancer Study Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-09-01
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.